SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANDRX (ADRX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rich1 who wrote (72)4/26/1998 7:57:00 PM
From: PAUL ROBERT ST. ONGE  Read Replies (1) of 127
 
Excellent article on IBD, states 19 generics under development,
2 filed, one NDA in phase II trials, 15 NDA studies expected to be in progress or filed by third quarter.

Distribution business going "gangbusters", topping 8,000 customers in the distribution business, Prilosec filing, litigation issues in favor of company, expecting to turn profitable next quarter, Watson's 18% stake in the company, expects to establish an international presence
etc. etc.

Basically as I stated before, this stock has a full tank of gas!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News